PaulNyirjesyMD

PubMed

• Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis.
  Stephen Brand, Jack D. Sobel, Paul Nyirjesy, Mahmoud A. Ghannoum, Robert J. Schotzinger, Thorsten P. Degenhardt> ;Clinical Infectious Diseases. 2020 Aug 20
• Management of Resistant Trichomoniasis.
  Cynthia Alessio, Paul Nyirjesy> ;Current Infectious Disease Reports. 2019 Aug 6
• CD101 Topical Compared With Oral Fluconazole for Acute Vulvovaginal Candidiasis: A Randomized Controlled Trial.
  Paul Nyirjesy, Cynthia Alessio, Alena Jandourek, Jon D Lee, Taylor Sandison, Jack D. Sobel> ;Journal of Lower Genital Tract Disease. 2019 Jul 1
• Re: A systematic review of drug treatment of vulvodynia: evidence of a strong placebo effect.
  Nyirjesy, P.,Sobel, J. D.> ;BJOG. 2019 Apr 09
• Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
  Junko Yano, Jack D. Sobel, Paul Nyirjesy, Ryan Sobel, Valerie Williams, Qingzhao Yu, Mairi C. Noverr, Paul L. Fidel> ;BMC Women's Health. 2019 Mar 29
• Long-Term Outcomes of Women With Recurrent Vulvovaginal Candidiasis After a Course of Maintenance Antifungal Therapy.
  Tess Crouss, Jack D. Sobel, Katharine Smith, Paul Nyirjesy> ;Journal of Lower Genital Tract Disease. 2018 Oct 1
• A systematic review of drug treatment of vulvodynia: evidence of a strong placebo effect.
  G Miranda Varella Pereira, M Soriano Marcolino, Z Silveira Nogueira Reis, M Vale de Castro Monteiro> ;BJOG : an international journal of obstetrics and gynaecology. 2018 Sep 1
• 2 citations
  A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.
  John E. Edwards, Michael M Schwartz, Clint S. Schmidt, Jack D. Sobel, Paul Nyirjesy, Florian Schodel, Erica Marchus, Mary Lizakowski, Elizabeth A DeMontigny, Jesse Hoe...> ;Clinical Infectious Diseases. 2018 Jun 1
• Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis.
  Schwebke, J. R.,Gaydos, C. A.,Nyirjesy, P.,Paradis, S.,Kodsi, S.,Cooper, C. K.> ;J. Clin. Microbiol.. 2018 Apr 13
• A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recu...
  Stephen Brand, Thorsten P. Degenhardt, Karen Person, Jack D. Sobel, Paul Nyirjesy, Robert J. Schotzinger, Amir Tavakkol> ;American Journal of Obstetrics and Gynecology. 2018 Jun 1
• Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment.
  Nyirjesy, P., Schwebke, J. R.> ;Future microbiology. 2018 Jan 13
• 1 citation
  A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vag...
  Schwebke, J. R., Morgan, F. G., Koltun, W. D., Nyirjesy, P.> ;American journal of obstetrics and gynecology. 2017 Sep 5
• Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers.
  Steven E. Chavoustie, Scott E. Eder, William D. Koltun, Tracey R. Lemon, Caroline Mitchell, Paul Nyirjesy, Jack D. Sobel, Ryan Sobel, Rachel Villanueva> ;International Journal of Gynecology & Obstetrics. 2017 May 1
• Chronic Cervicitis: Presenting Features and Response to Therapy.
  Mattson SK, Polk JP, Nyirjesy P> ;J Low Genit Tract Dis. 2016-07-01
• A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections
  Elissa Meites, Charlotte A. Gaydos, Marcia M. Hobbs, Patricia Kissinger, Paul Nyirjesy, Jane R. Schwebke, W. Evan Secor, Jack D. Sobel, Kimberly A. Workowski> ;Clinical Infectious Diseases. 2015 Dec 15
• Trichomonas vaginalis Infection in a Tertiary Care Vaginitis Center.
  Keating MA, Nyirjesy P> ;Sex Transm Dis. 2015-09-01
• New Perspectives on the Normal Vagina and Noninfectious Causes of Discharge.
  Powell, A. M., Nyirjesy, P.> ;Clinical obstetrics and gynecology. 2015 Jul 1
• Non-albicans Candida Vulvovaginitis: Treatment Experience at a Tertiary Care Vaginitis Center.
  Powell, A. M., Gracely, E. J., Nyirjesy, P.> ;Journal of lower genital tract disease. 2015 Jun 18
• Metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis: a dose-ranging study.
  Chavoustie SE, Jacobs M, Reisman HA, Waldbaum AS, Levy SF, Hillier SL, Nyirjesy P> ;J Low Genit Tract Dis. 2015-04-01
• Comment on "Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition".
  Orna Reichman, Micheline Moyal-Barracco, Paul Nyirjesy> ;Journal of Lower Genital Tract Disease. 2015 Jan 1
• Management of persistent vaginitis.
  Nyirjesy, P.> ;Obstet Gynecol. 2014 Nov 22
• Recurrent vulvovaginitis.
  Powell, A. M.,Nyirjesy, P.> ;Best Pract Res Clin Obstet Gynaecol. 2014 Sep 16
• Iliopsoas abscess: an unexpected sequela of dilation and evacuation.
  Pereira N, Bardawil EC, Patel MA, Brannon RK, Podolsky ML, Nyirjesy P> ;J Low Genit Tract Dis. 2014-04-01
• 60 citations
  Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical st...
  Paul Nyirjesy, Jack D. Sobel, Albert Fung, Cristiana Mayer, George Capuano, Kirk Ways, Keith Usiskin> ;Current Medical Research and Opinion. 2014 Feb 12
• 19 citations
  Genital Mycotic Infections in Patients With Diabetes
  Paul Nyirjesy, Jack D. Sobel> ;Postgraduate Medicine. 2013 May 1
• Join now to see all